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ABSTRACT 
 
Calpain and Lipopolysaccharide Mediated Hepatitis.  (August 2006) 
 
Robert Edward Rose, B.S., Texas A&M University; 
 
D.V.M., Texas A&M University 
 
Chair of Advisory Committee:  Dr. Shashi K. Ramaiah 
 
 
This study tested the role of the calcium dependent cytosolic protein calpain in 
neutrophilic hepatitis.   We hypothesized that inhibition of calpain would protect against 
LPS-induced neutrophilic liver damage.  To test our hypothesis, a reliable LPS-mediated 
hepatitis model to investigate the mechanisms of hepatic neutrophil infiltration following 
LPS administration was developed by repeat intravenous injection of LPS at a dose of 10 
mg/kg to rats.    Blood was collected for hematologic and biochemical analysis and 
multiple organs including liver were collected for evaluation of histopathologic changes.  
Flow cytometry was employed to investigate L-selectin (CD 62L) and MAC-1 
(CD11b/18) expression on neutrophils both in vivo and in vitro.   Significant hematologic 
changes included neutrophilia, elevation in neutrophil to lymphocyte ratio with toxic 
changes and left shift. Biochemical changes were observed in several liver (AST, GGT) 
and kidney (BUN) parameters generally at the earliest time points.  Histopathology 
revealed a time-dependent neutrophil and mononuclear infiltration around the periportal 
areas in the single dose study and mid-zonal inflammation with multifocal coagulative 
necrosis in the repeated dose study. CD 11b was up-regulated both in vitro and in vivo. 
After development of a suitable model, the first goal was to investigate the role of the 
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intracellular enzyme calpain in the development of neutrophilic hepatitis and midzonal 
necrosis.  A second goal was to compare the observed protective effects of calpain 
inhibition with a relatively selective inducible nitric oxide synthase (iNOS) inhibitor 
aminoguanidine and an inhibitor of coagulation, heparin.  When compared to rats 
administered LPS alone, administration of calpain 1 inhibitor prior to LPS significantly 
reduced hepatic iNOS expression, hepatic neutrophil infiltration and attenuated midzonal 
hepatic necrosis.  Administration of heparin and aminoguanidine prior to LPS also 
decreased liver iNOS expression, hepatic neutrophil infiltration and liver pathology 
comparable to calpain inhibition. Blood neutrophil activation, as measured by the 
neutrophil adhesion molecule CD11b integrin, was upregulated in all the LPS treated 
groups regardless of inhibitor administration. We conclude that amelioration of liver 
pathology via calpain inhibition is likely dependent on the down-regulation of iNOS 
expression in the rat model of LPS mediated hepatitis. 
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CHAPTER I  
INTRODUCTION 
Lipopolysaccharide (LPS, endotoxin) is a component of the outer membrane of 
the cell wall of gram negative bacteria, which are often normal inhabitants of the 
mammalian intestinal tract (Uesugi et al., 2002).  Enteric bacterium often serve as a 
source for systemic LPS exposure and under certain conditions, such as those associated 
with chronic alcohol consumption, increased gut derived LPS is released into the portal 
circulation (Keshavarzian and Fields, 2003; Uesugi et al., 2002). LPS from lysed gram 
negative bacteria entering the blood stream is bound by lipopolysaccharide binding 
protein.  Protein bound LPS interacts with CD14 receptors on monocytes and 
macrophages, including hepatic Kupffer cells, setting off a series of pro-inflammatory 
events (Bautista, 2002; Limaye et al., 2003).  First, CD14 mediated activation of the 
toll-like receptor 4 results in NF-κB regulated production of cytokines, including IL-1β, 
IL-6, IL-8, TNF-α and platelet-activating factor along with upregulation of the 
inducible isoform of nitric oxide synthase (iNOS) (Kamanaka et al. 2003; Luyendyk et 
al., 2003; Nagy, 2003).    These strong mediators of inflammation initiate a cascade, 
which can lead to neutrophil activation and generation of reactive oxygen species 
(ROS) (Enomoto et al. 2000).   
_______________ 
This thesis follows the style of Toxicologic Pathology.  
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Activated neutrophils express surface adhesion molecules, such as L-selectin 
and Mac-1 (CD11b/18), which bind with complementary adhesion molecules, such as 
ICAM-1 and VCAM-1, on vascular endothelium promoting hepatic transmigration 
(Jilma et al. 1999; Picker, 1999). Concurrent with neutrophil activation, LPS mediated 
circulatory changes including reduced mean arterial pressure, formation of 
microthrombi and altered microcirculation, impair hepatic perfusion and promotes 
leukocyte adhesion with subsequent tissue transmigration (Asakura et al., 2005; Palmes 
et al., 2004).  Transmigrated neutrophils can elicit tissue damage through release of 
ROS, proteolytic enzymes and additional chemotactic factors further driving neutrophil 
mediated hepatitis (Ikeda and Young, 2002). 
Several animal models of endotoxemia with concurrent hepatic inflammatory 
lesions are reported in literature which include parenteral injections of LPS along with 
surgical preparations such as the cecal ligation and puncture technique (Parker and 
Watkins, 2001).   However, there are no well accepted animal models of endotoxemia 
with hepatic neutrophil infiltration and necrosis in literature that is consistently 
reproducible.   Furthermore, the exact dose and route of LPS administration has also not 
been standardized in endotoxemic hepatitis models. Generally speaking, endotoxemic 
hepatitis animal model usually should exhibit at least one characteristic of the human 
condition, be reproducible and be developed in a manner consistent with humane 
animal care and use.  In addition, a reliable animal model should provide markers of 
organ injury that allow mechanisms of disease of interest to be thoroughly investigated.  
Historically, some of the markers of  LPS mediated hepatic damage have included 
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increased serum activity of the hepatic intracellular enzymes alanine aminotransferase 
(ALT) and/or aspartate aminotransferase (AST) (Suliburk et al., 2005), hepatic 
neutrophil transmigration (Bautista, 2002; Vadjova et al., 2000.), apoptosis (Tsuchiya et 
al., 2004), and hepatocellular necrosis (Ou et al., 1997, Yee et al., 2003).  However, 
systematic serum biochemical and histologic alterations following LPS-induced 
neutrophilic hepatitis in rats have not been investigated on a temporal basis.  The 
second chapter of this thesis describes the development of a suitable animal model to 
test our hypothesis concerning calpain and lipopolysaccharide mediated hepatitis.   
Recent literature suggests that calpain may play an important role in liver injury 
induced by hepatotoxicants such as carbon tetrachloride and acetaminophen (Limaye et 
al., 2003; Mehendale and Limaye, 2005). Limaye et al. (2003) reported that Calpain 
inhibitor substantially decreased the progression of liver injury and led to protection 
against carbon tetracholoride-induced lethality. Emerging evidence also suggests the 
role of calpain as a pro-inflammatory molecule by activation of nuclear factor kappa-B 
(NF-κB) (Picker, 1999; Riedemann et al., 2003) and the subsequent production of a 
variety of pro-inflammatory mediators including tumor necrosis factor alpha, 
interleukins such as IL-1β, IL-6, and IL-8, and cell adhesion molecules such as VCAM-
1 and ICAM-1 (Eipel, et al., 2004, Czermak, et al., 1999).  However, the role of calpain 
in endotoxin-mediated hepatitis is currently not known and is the basis of this 
investigation as described in Chapter III.  
Because of the exclusive midzonal necrosis noted in our model and association 
of such lesions with LPS mediated hypotension and microvascular disturbance, the role 
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of iNOS and coagulation was also investigated in this study.   Excessive production of 
nitric oxide (NO) as a consequence of macrophage release of iNOS contributes to the 
hypotension that is a feature of endotoxemia (Imai et al., 1994; Landry and Oliver, 
2001). Recent reports have demonstrated the pathological role of iNOS in models of 
disseminated intravascular coagulation (DIC) (Asakura et al., 2005) and acetaminophen 
toxicity (Kamanaka et al., 2003). We thus compared the results of calpain inhibition 
with those of an iNOS inhibitor aminoguanidine and an inhibitor of coagulation and 
microthrombi formation, heparin.  Finally we evaluated the effect that calpain inhibition 
has on expression of the cytochrome P450 enzyme, CYP2E1, in our model of LPS 
mediated hepatitis.  CYP2E1 was selected as it is known to be down regulated in 
inflammatory conditions and it has been suggested that nitric oxide (NO) may play a 
role in reduced CYP expression consequent to LPS exposure which may have vascular 
function implications (Udosen et al., 2003). It is our hypothesis that amelioration of 
liver pathology via calpain inhibition is likely dependent on the down-regulation of 
iNOS expression in the rat model of LPS mediated hepatitis. 
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CHAPTER II   
DEVELOPMENT OF THE NEUTROPHILIC HEPATITIS MODEL 
MATERIALS AND METHODS 
Animals and treatment   
All animal procedures were approved by the Texas A&M University Laboratory 
Animal Care Committee (ULACC) and conformed to the standards set forth in the 
Guide for the Care and Use of Laboratory Animals (NRC 1996).  Commercially 
obtained Sprague-Dawley (SD) rats (250-270 g body weight; Harlan, Indianapolis, IN) 
employed in this study were barrier raised and housed in an AAALAC accredited 
facility.  Standard rodent chow (Teklad 8604, Madison WI) and reverse osmosis filtered 
water were supplied ad libitum. 
 Single LPS dose experiments: Male SD rats were divided into experimental and 
control groups (n = 4 in each group).  The experimental groups were administered LPS 
(E Coli serotype 0111: B4, Sigma Chemical Co., St Louis, MO) in saline at a dose of 5 
or 10 mg/kg compounded to yield a dose volume of 1 ml/kg intravenously via tail vein 
injection.  Two control groups were employed.  One control group received saline at a 
dose volume of 1 ml/kg with the second control group not subjected to saline or LPS 
injection.  Following treatment, the rats were euthanized via CO2 at 0 (untreated 
control), 12, 24 and 48 hrs post LPS or vehicle administration (Figure 1). 
Repeated two dose experiments: Male SD rats were divided into three groups (n 
=5 in each group) and administered LPS in saline twice, 24 hours apart, via tail vein 
injection at a dose of 10 mg/kg.  The rats were sacrificed via CO2 at 6, 12, and 24 hours 
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post second injection of LPS (Figure 1).  The selection of LPS dose and sacrifice time 
points was based on the results of the single dose study.  A follow up repeat dose study 
(n=5 in each group) to confirm the results of the first repeat dose experiment was 
performed with LPS administration route, dose, and sample time points identical to the 
first study. 
 
Single dose LPS (5 or 10 mg/kg, iv)
-24           0        6         12       24        48  
Rats Sacrificed (Time in hrs)
Repeat dose LPS (10 mg/kg, iv, 24 hrs apart) Rats Sacrificed (Time in hrs)
Figure 1- Experimental scheme to demonstrate single and repeated two dose LPS injections in 
relation to sample collections in Sprague Dawley rats. 
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Sample harvesting and processing  
 Blood from the single and repeated dose study was collected via the abdominal 
vena cava and divided into three separate tubes. An EDTA tube (Terumo Medical Co, 
Elkton, MO) was employed for determination of complete blood count (CBC) on a 
Cell-Dyn 3700 (Abbott Diagnostics, Abbott Park, IL) hematology analyzer. A serum 
tube (Monoject, Sherwood Medical, St Louis, MO) was used for clinical chemistry 
determinations using a Hitachi 911 (Roche, Indianapolis, IN) chemistry analyzer. The 
remainder of the blood was placed into a lithium heparin tube (Monoject, Sherwood 
Medical, St Louis, MO) for determination of neutrophil adhesion molecule expression.  
Blood smears were made from the EDTA blood and stained for manual hematology 
evaluation.  Serum was separated from red blood cells by centrifugation at 4000 rpm for 
10 minutes and plasma separated from lithium heparin tubes was stored at -70° C for 
later analysis. Representative liver sections were collected from different lobes of the 
liver and placed in liquid nitrogen and stored at   -70° C until further analysis.  The 
remaining liver and other organs (kidney, lungs, intestines, brain and spleen) were 
collected and placed in 10% neutral buffered formalin for histopathological evaluation 
and chloracetate esterase staining for neutrophils as previously described (Banerjee et 
al., 2006). 
Flow cytometry studies  
 To further evaluate neutrophil stimulation, in vitro and in vivo experiments were 
designed to assess the neutrophil adhesion molecules, L-selectin (CD62-L) and Mac-1 
(CD 11b/18).  In these studies, blood was collected from rats via cardiac puncture 
directly into lithium heparinized tubes (Monoject, Sherwood Medical, St Louis, MO) 
and was stored on ice until processing.  Blood was divided into 250 uL aliquots in 
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separate glass tubes and was kept on ice unless otherwise stated.  Duplicate tubes of 
blood were designated to antibody stained or unstained groups.  
For the in vitro experiments, neutrophils were stimulated in vitro with LPS prior 
to antibody staining using a dose of 0.04 mg of LPS dissolved in 10 uL of distilled 
water per sample to mimic an i.v. dose of 10 mg/kg for a 250g rat.  After the addition of 
LPS, tubes were gently shaken in a warm water bath at 37° C for 30 minutes.  All but 
unstained samples were incubated with 10µl of reagent grade mouse IgG (Sigma, St 
Louis, MO) mixed at a concentration of 1mg/ml, to reduce nonspecific binding of the 
conjugated antibodies.  Neutrophils were labeled with fluorescein-conjugated HIS 48 
(BD Biosciences, San Jose, CA) to allow for identification via flow cytometry.  Mac 1 
integrins were labeled with R-phycoerythrin conjugated CD11b (Serotec Inc., Raleigh, 
NC) and L-selectins were labeled using R-phycoerythrin CD62L (Serotec Inc., Raleigh, 
NC).  Following incubation with antibodies (20 min), the samples were treated with 
RBC lysis buffer for 2 min.  The tubes were then centrifuged at 1000 rpm for 10 min at 
3° C and resuspended several times until erythrocytes were removed.  After lysing 
steps, the cells were washed with 50 µL of PBS and centrifuged at 1000 rpm for 10 
minutes. Cells were suspended in 300 µL of PBS prior to analysis.  
 For determination of neutrophil activation in vivo, flow cytometry was 
performed using blood collected from both single and repeat LPS dose studies. Briefly, 
heparinized blood collected from single 10 mg/kg LPS dose at the 12 hour time point 
(n=3) and blood collected from repeat LPS dose  at the 6 hour time point (n=3) were 
used to assess levels of CD11b and CD62L expression on neutrophils and compare their 
levels with in vitro studies.    Blood collected from naive rats (n=3 both single and 
repeat dose) were employed as controls. The blood was processed for flow cytometry 
identical to the in vitro samples.  
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The cells were analyzed using a FACS Calibur (Becton Dickinson 
Immunocytometry Systems, San Jose, CA) flow cytometry, equipped with a 15mW air-
cooled argon laser. Green fluorescence from fluorescein was collected through a 
530/30-nm bandpass filter and orange fluorescence from R-phycoerythrin through a 
585/42-nm bandpass filter. List mode data were acquired on a minimum of 10,000 
events defined by light scatter gates to include the neutrophil population. Data analysis 
including spectral compensation was performed using FlowJo (Treestar Inc., Ashland, 
OR).  A neutrophil gate was established based on side scatter and positive HIS48 
staining, and the median fluorescence channel was determined for CD11b staining. 
Statistics 
 To identify significant differences among groups, analysis of variance 
(ANOVA) with a post hoc Tukey’s HSD was performed using a computer software 
program (SPSS version 12.0, Claritas Inc.).  Results were considered significant at the 
0.05 confidence level. 
RESULTS 
 There were no significant statistical differences in hematology, serum chemistry 
or hepatic neutrophil counts between the untreated and saline treated controls in the 
single dose study.  For ease of reporting and to increase statistical power, both control 
groups were reported together in the results section.  In order to reduce animal numbers, 
saline and untreated controls from the single dose study provided control group values 
for the repeat dose study. Since both repeat dose studies were identically performed, 
results presented reflect both studies.  
Clinical signs 
 Single and repeat dose studies:  Rats were lethargic as compared to controls 
within 1 hour of dosing and developed diarrhea within 3 hours of LPS administration.  
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Increased activity and a resolution of diarrhea was noted approximately 24 hours after 
LPS was discontinued. 
Hematology findings  
 Single dose experiment:  The most significant and consistent finding in the LPS 
group compared to the controls was the absolute increase in neutrophil numbers at 12 
and 24 hours post LPS.   The increase in N:L ratio peaked at 12 hours post LPS dose 
and started declining at 24 hours post LPS dose with almost control levels reached by 
48 hours post LPS dosing at both dose rates.  Changes in absolute counts for both 
neutrophils and lymphocytes contributed to the increased N:L ratio at 12 and 24 hours 
post dose.  Absolute neutrophil numbers increased while lymphocyte numbers 
decreased at 12 and 24 hours (Table 1).   The post dosing elevation in neutrophils and 
decline in lymphocytes was absent by 48 hrs post LPS dosing as reflected by a normal 
N:L ratio.  Mild but infrequent monocytosis was present 48 hrs post LPS injection at 10 
mg/kg LPS (data not shown).  The platelet numbers were significantly decreased in the 
LPS treated group compared to controls with frequent clumping present throughout the 
blood smear.  There were no alterations in the hematocrit noted between control and 
experimental groups. 
 Repeated dose study:  Absolute neutrophil numbers were significantly higher at 
the 6 and 12 hr time point compared to the control with a trend of decline by 24 hr time 
point following the second LPS injection (Table 2).  Absolute lymphocyte numbers 
were significantly reduced at the 6 hour time point as compared to the 12 and 24 hr time 
point. Consequent to increased neutrophils and decreased lymphocytes at the 6 hour 
time point, the neutrophil to lymphocyte ratio was significantly elevated at 6 hours as 
compared to the 12 and 24 hour time points.  Monocytosis was significantly elevated at 
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the 24 hour time point post second LPS injection.  Nucleated red blood cells were 
present at all three time points in this study (Table 2). 
 
Table 1-  Select hematology and serum biochemistry values from single intravenous 5 
or 10 mg/kg dose LPS in male Sprague Dawley rats. 
 
 Dose Control  5 mg/kg  
Time point  12 hour 24 hour 48 hour 
WBC #/µl 13462 ± 542 10025 ± 792 10925 ± 668 12475 ± 776 
Neutrophil  #/µl 1591 ± 209 6511 ± 902* 5710 ± 724* 3228 ± 254 
Lymphocyte 
#/µl 
11658 ± 536 3315 ± 807* 5096 ± 573* 9126 ± 862 
N:L ratio .15 ± 0.3 2.3 ± .6* 1.2 ± .6 .4 ± .1 
Albumin g/dl 4.4 ± .05 3.8 ± .04* 3.5 ± .17* 3.4 ± 0* 
BUN mg/dl 20.2 ± .49 42.6 ± 3.8 37.7 ± 6.1 28.2 ± 1.0 
AST U/l 77.6 ± 2.3 192.3 ± 32.6 134.8 ± 29.1 61.0 ± 5.8 
ALT U/l 65.1 ± 1.9 66.2 ± 6.3 41.8 ± 9.8 27.8 ± 1.0 
CK U/l 190.6 ± 13.1 209.3 ± 58.2 131.0 ± 17.1 134.5 ± 15.3 
Dose Control  10 mg/kg  
Time point  12 hour 24 hour 48 hour 
 
WBC #/µl 13462 ± 542 9600 ± 962 9825 ± 1581 11950 ± 688 
 
Neutrophil  #/µl 1591 ± 209 6338 ± 437* 4550 ± 1314* 2637 ± 667 
Lymphocyte 
#/µl 
11658 ± 536 3215 ± 643* 5212 ± 1368* 8561 ± 422 
N:L ratio .15 ± 0.3 2.1 ± .3* 1.1 ± .5 .3 ± .1 
 
Albumin g/dl 4.4 ± .05 3.7 ± .18 * 3.7 ± .17* 3.1 ± .15* 
 
BUN mg/dl 20.2 ± .49 108.9 ± 51.5 # 43.4 ± 13.3 45.7 ± 3.4 
AST U/l 77.6 ± 2.3 352.0 ± 166.1* 255.8 ± 123.9 83.0 ± 26.4 
ALT U/l 65.1 ± 1.9 164.3 ± 94.1 154.8 ± 110.9 47.5 ± 19.9 
CK U/l 190.6 ± 13.1 321.5 ± 96.0* 148.0 ± 11.7 136.3 ± 11.5 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Serum chemistry was assayed using Hitachi 911 and complete blood count was analyzed on a 
Cell-Dyn 3700 analyzer followed by manual evaluation as described in the Materials and 
Methods section.  
 * Values significantly different form the controls, p < 0.05. 
 N=16 (control), N = 4 (LPS groups), Values are mean ± SE  
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Table 2- Select hematology and serum biochemistry values following repeat dose 10 
mg/kg  LPS  administration in male Sprague Dawley rats. 
 
Time point Control 6 hour 12 hour 24 hour 
WBC #/µl 13462 ± 
542 
8066 ± 
2004 
12450 ± 
697 
12600 ± 781 
 
Neutrophil  #/µl 1591 ± 209 4855 ± 
1237* 
4767 ± 
1403* 
3001 ± 287 
Lymphocyte #/µl 11658 ± 
536 
2881 ± 
369#  
7278 ± 
788* 
8751 ± 733* 
N:L ratio .15 ± 0.3 1.8 ± .2# .74 ± .1* .37 ± .05 
 
Nucleated RBC  0 1.5 ± .7 .7 ± .4 .3 ± .3 
 
Albumin g/dl 4.4 ± .05 3.4 ± .13* 3.2 ± .19* 3.1 ± .1* 
 
BUN mg/dl 20.2 ± .49 79.5 ± 
17.5* 
52.6 ± 6.3 48.5 ± 10.5 
Creatinine mg/dl .24 ± .01 .59 ± .13* .33 ± .02 .34 ± .02 
 
AST U/l 77.6 ± 2.3 281.7 ± 
42.9* 
138.3 ± 
19.9 
69.3 ± 6.9 
ALT U/l 65.1 ± 1.9 90.6 ± 28.3 45.0 ± 7.9 36.4 ± 3.1 
ALP U/l 202.3 ± 6.6 463.9 ±  
118.7#
247.9 ± 
21.4 
175.6 ± 10.6 
GGT U/l < 3 ± 0 21.0 ± 9.6* 5.4 ± 1.6 < 3 ± 0 
 
Total bilirubin .13 ± .01 .26 ± .02* .24 ± .02* .17 ± .02 
 
CK U/l 190.6 ± 
13.1 
344.1 ± 
47.2* 
366.9 ± 
62.9* 
250.1 ± 49.1 
 
Serum chemistry was assayed using Hitachi 911 and complete blood count was analyzed on a 
Cell-Dyn 3700 analyzer followed by manual evaluation as described in the Materials and 
Methods section.  
* Values significantly different form the controls, p < 0.05. 
# = Values significant as compared to controls and other dose groups, , p≤ .05   
N=16 (control), N = 10 (LPS groups), Values are mean ± SE  
GTT values below 3 U/l are reported as <3 by the laboratory 
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Serum chemistry findings 
 Single dose experiment: Biochemical changes were mostly noted in serum 
albumin, blood urea nitrogen (BUN), aspartate aminotransferase (AST) and creatinine 
kinase (CK) levels in the LPS treated groups.  A mild but significant decrease in 
albumin levels was noted following LPS injection at all points following LPS injection 
at both LPS doses.   Increased BUN levels were noted at early time points post LPS 
injection at both the doses although the elevation was much higher in the repeat dose 
study (Table 1).  AST levels were consistently elevated in both the doses at 12 and 24 hr 
time point with the relative degree of elevation much higher at the 10 mg/kg dose 
(Table 1).   Alanine aminotransferase (ALT) values were inconsistent with some 
extreme elevated outliers in several LPS dosed groups and multiple instances of 
lowered values compared to the control group. CK levels were minimally elevated as 
compared to controls in the 12 hour 10 mg/kg dose group (Table 1).  
 Repeated two dose study: Serum chemistry revealed elevations of AST, total 
bilirubin, alkaline phosphatase (ALP), gamma glutamyl transferase (GGT), BUN and 
creatinine generally at the 6 hour time point as compared to control ranges established 
in the single dose study (Table 2).  Parameters used to evaluate hepatobiliary injury; 
AST, ALP and GGT had significantly increased levels at 6 hours but were no longer 
significantly elevated by the 12 hour time point (Table 2). BUN and creatinine were 
elevated at 6 hours as compared to the 12 and 24 hour time points.  CK levels were 
increased compared to controls at the 6 hour time point. Similar to the single dose 
study, albumin levels were significantly decreased as compared to established controls 
at all three time points. 
Microscopic examination of stained blood films 
 Single and repeated two dose experiment:  Microscopic examination revealed 
significant immaturity in neutrophils as indicated by immature nuclear chromatin 
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pattern, band and donut neutrophils (Fig 2B).  Toxic changes were present within 
neutrophils at all the doses of LPS, although the toxic changes were much higher in the 
repeat dose study.  Toxic changes were evaluated based on the presence of one or more 
of the following as described in Veterinary literature (Lattimer et al., 2003); Dohle 
bodies, increase cytoplasmic basophilia, vacuolated cytoplasm and cytoplasmic 
granulation.  Toxic changes such as Dohle bodies and occasional toxic granulation and 
were present in both low and high dose LPS dosing (Fig 2C & D).  The presence of 
nucleated red blood cells was a consistent finding in the repeat dose experiment but was 
absent in the single dose study.  
Organ pathology   
 Single dose experiment:  Histopathology revealed minimal periportal infiltrate 
of neutrophils in the liver at 12 hours post dose.  By 24 to 48 hours the periportal 
infiltrate was predominately mononuclear (Fig 3B).  A slight increase in hepatocellular 
apoptosis and mitosis was identified to 48 hour post dose sections (Fig 3F).  There were 
no histopathological alterations identified in other organs collected. 
 Repeated two dose study:   Histopathology revealed marked multifocal midzonal 
neutrophilic hepatic necrosis/apoptosis accompanied by a predominately mononuclear 
periportal infiltrate (Fig 3C, 3D, 3E).  Necrosis progressed from 6 to 12 hours post 
second dose.  By the 24 hour time point, necrotic foci were being replaced by 
regenerating hepatocytes in some regions.  Regeneration was marked by increased 
hepatocyte mitosis and megalocytosis as compared to control rats. 
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Ctrl, 20X 50X
A B
C D
50X 50X
 
Figure 2- Microscopic examination of Wright-Giemsa stained blood film following 
single (5 or 10 mg/kg) and repeated two dose (10 mg/kg) LPS injections.  2A: control 
blood (20X); 2B: representative left shifted stab (donut) neutrophil single dose (50X); 
2C & D: representative toxic neutrophils  single and repeated two dose.  
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Figure 3- Microscopic examination of liver following single (5 or 10 mg/kg) and repeated two 
dose (10 mg/kg) LPS injections.  3A: control; 3B: single dose (10mg/kg 24 hr) showing 
representative periportal infiltrate (arrow), P- periportal region; 3C: repeated two dose at 6 hr 
showing representative midzonal necrosis (arrows).  3D: repeated two dose at 12 hr showing 
representative midzonal necrosis (arrows). 3E: repeated two dose at 24 hr showing 
representative midzonal necrosis (arrows).  3F: Single dose LPS 10mg/kg at 48 hr illustrating 
liver regeneration with increased mitotic figures (arrows)    H&E stain.  
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Enumeration of hepatic neutrophils  
 Chloroacetate esterase staining of liver sections revealed increased numbers of 
extravasated neutrophils from the sinusoids.  Hepatic neutrophil numbers were greatest 
at the early time points in both single and two dose experiments as compared to later 
time points.  Extravasated neutrophil counts were highest at the 6 hour time point in the 
two dose study and coincided with the observed midzonal necrosis.  In both single and 
two dose experiments, neutrophil counts diminished in a temporal fashion (Fig 4).  
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Figure 4- Graphs illustrating hepatic neutrophil counts using chloroacetate esterase staining of liver 
sections.  Bars represent mean value of neutrophils counted in 10 high power fields (20X). 
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Flow cytometry studies    
 In single dose LPS study, analysis of neutrophil adhesion molecule expression 
revealed an up regulation of L-selectin (CD62-L) and Mac1 (CD11b) in vitro. However, 
in vivo, there was down regulation of L-selectin and up regulation of Mac1 (CD11b) in 
the LPS treated neutrophils as compared the controls (Fig 5). In the repeat dose study, 
upregulation of Mac 1 (CD11b) 6 hours post second LPS dose was the only significant 
finding. CD62L expression was not significantly different from control values (Fig. 5). 
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Figure 5- Flow cytometry results. Expression of  5A: Mac 1 and 5B: L-selectin: following in vitro 
and in vivo stimulation of neutrophils with single dose LPS at 10 mg/kg; 5C: Mac 1 following in 
vivo stimulation at 6 hr post repeat dose LPS administration. 
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DISCUSSION 
 We developed a reproducible endotoxemic necroinflammatory hepatitis rat 
model to study mechanisms of LPS mediated neutrophilic hepatitis and necrosis.  A 
single dose of LPS elicited a profound peripheral neutrophilia with concurrent 
neutrophil activation (evidenced by upregulation of the neutrophil CD11b and 
downregulation of L-selectin) and increased neutrophil infiltration into hepatic 
parenchyma.  In spite of adequate blood neutrophil activation and hepatic neutrophil 
infiltration, hepatic necrosis was minimal to none in the single dose study.  Because our 
goal was LPS mediated hepatitis and necrosis, we decided to administer a second dose 
of LPS in an effort to induce histologically evident liver necrosis.  Since, peripheral 
neutrophilia was most evident at the earliest time points when measured in a temporal 
fashion we selected 6 hr time point in the repeat dose study.  Sample collection was 
terminated 24 hr after the second dose when neutrophilia began to wane in the repeat 
dose study.   
 The peripheral neutrophila noted both in the single and repeat dose study is not 
surprising given the well known inflammatory effect elicited by LPS.  Mechanistically 
speaking, LPS binds to LPS binding protein (LBP) in the blood which interacts with the 
CD14 plasma membrane receptor on macrophages such as hepatic Kupffer cells 
(Bautista 2002; Muta and Takeshige, 2001).  This complex then activates Toll-like 
receptor 4 (TLR-4) on the macrophage (Aderem and Ulevitch, 2000) resulting in the 
activation of NF-kB followed by transcriptional upregulation of pro-inflammatory 
cytokines (tumor necrosis factor alpha (TNF-a), IL-1β, IFN-g) and CXC chemokines 
(IL-8 (rodent equivalent cytokine induced neutrophil chemoattractant (CINC) 
(Cuzzocrea et al., 2000; Muta and Takeshige, 2001; Tsuji et al., 2005).  TNFα and IL-
1ß are known to stimulate leukocyte release from the bone marrow post maturation 
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storage pool (Picker, 1999) which is most likely responsible for the observed peripheral 
neutrophilia.  The persistence of LPS-elicited inflammatory response is supported by 
the immature forms of neutrophils noted in this study.  The lymphopenia noted may be 
attributed to the endogenous corticosteroid effect (Aster and Kumar, 1999). 
 The presence of nucleated red blood cells in the repeat dose LPS group most 
likely suggests their release from the marrow due to existing toxic environment in the 
bone marrow, although splenic release cannot be ruled out.  As an adjunct to absolute 
neutrophil counts we assessed two CD11b and CD62L to determine peripheral 
neutrophil activation and possibly correlate neutrophil activation with hepatic 
neutrophil extravasation and infiltration in this model.  Shedding of L-selectin and 
upregulation of CD11b is employed as a marker of peripheral neutrophil activation and 
usually    precedes hepatic neutrophil extravasation (Bajt et al., 2002; Gujral et al., 
2003) 
 Flow cytometry of neutrophils exposed to a single dose of LPS in vivo 12 hours 
prior to collection showed an up regulation of CD11b and a down regulation of CD62L 
which is consistent with neutrophil activation (Gujral et al., 2003).  Neutrophil 
activation correlated with increased hepatic neutrophil extravasation and infiltration yet 
necrosis was not noted in the single dose study.  An unexpected but interesting finding 
was noted with the L-selectin levels following exposure to LPS in vitro.  There was 
upregulation of L-selectin in vitro compared to down regulation in vivo.  This 
discrepancy of L-selectin expression in vitro versus in vivo (single dose) may be the 
result of duration of time between LPS exposure and flow cytometric analysis (30 
minutes exposure in vitro versus 12 hours in vivo).  Similar findings are reported after 
intravenous administration of LPS to human volunteers where expression of L-selectin 
slightly increased from baseline values soon after dosing (90 minutes) before falling to 
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90% of baseline levels 6 hours post dosing (Jilma et al., 1999).  Nonetheless, in the 
repeat dose study, CD11b expression was upregulated, hepatic neutrophil infiltration 
was increased and necrosis was also evident which was clearly absent in the single dose 
study.  These results suggest that although neutrophil activation may predict hepatic 
neutrophil infiltration, hepatic necrosis may not be the sequale as was noted in this 
study.   
 Serum chemistry changes in both the single and repeat LPS study represents 
subtle but some interesting findings.  BUN elevation noted is likely a secondary 
dehydration response to  reduced water intake post LPS administration.  The elevation 
in BUN is not likely a result of renal pathology based on the concurrent lack of 
clinically relevant persistent elevation in serum creatinine and no detectable renal 
histologic alterations. Reductions in serum albumin documented in LPS treated rats is 
likely secondary to GI loss associated with the LPS induced diarrhea.  Elevations in 
GGT in repeat dose LPS treated rats at 6 hours is an interesting finding.  Although GGT 
elevations can be identified in hepatic cholestasis (Latimer et al., 2003), cholestasis is 
less likely based on the absence of detectable cholestasis on histopathology.  Based on 
the periportal mononuclear infiltration and bile duct proliferation noted, the elevation in 
GGT is possibly contributed from the proliferating biliary epithelium.  In the absence of 
histologically evident cholestasis, the mild elevation in total bilirubin and ALP seen in 
the repeat dose study may be attributed to anorexia or endotoxemia (Crawford et al., 
1998).   Although AST elevations at the early time points in both single and repeat dose 
studies may suggest liver injury, the concurrent increase in CK suggests the elevation 
due to muscle injury.  Muscle injury may have resulted from prolonged periods of LPS 
induced lethargy resulting in inactivity and subsequent pressure necrosis of muscles 
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bearing a recumbent animal’s weight.  Due to the fact that saline treated controls did not 
exhibit CK elevations, injections were not likely the cause of this increase.   
 The lack of consistent increase in ALT with marked hepatic necrosis in the 
repeat dose study is a surprising observation in this study.   Two reasons can be 
attributed to this finding.  First, it is known that pyridoxal 5' phosphate (P5P) an active 
metabolite of vitamin B6 is an essential cofactor for maximum serum transaminase 
activity (Stokol and Erb, 1998).  Reduced vitamin B6 either due to decreased food 
intake or GI loss may be contributing to the lack of elevated serum transaminase values 
in this study.  Due to limitations in the serum sample, we did not measure serum P5P or 
repeat the assay with the addition of P5P to confirm our findings.  Another possibility is 
the half life of serum transaminases.  Serum ALT half life is on the order of 40-60 hrs in 
several veterinary species (Lattimer et al., 2003) but no definitive studies have been 
carried out in the rat to accurately determine half life of this enzyme.  The fact that there 
was demonstrated histologic evidence of hepatocellular damage after repeated doses of 
LPS but no associated ALT elevation may possibly indicate reduced half life of ALT in 
rats in the present study.  Thus, to detect liver necrosis, caution should be exercised 
while interpreting the traditionally measured serum chemistry parameters in the LPS 
necrohepatitis model.      
 Clearly, a single dose of LPS was not sufficient to produce significant 
histopathological lesions in any of the tissues examined although there was mild 
mononuclear cell infiltrate in hepatic periportal regions.  Similarly other investigators 
have shown single doses of LPS to be ineffective in producing significant 
histopathological lesions in the liver (Pirisi et al., 2000). Although not a feature on H&E 
stained tissue, chloracetate esterase staining of neutrophils revealed increased 
neutrophils near the periportal venule and within the sinusoids at all time points as 
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compared to controls in the single dose study.  Based on this it can be surmised that the 
degree of neutrophil transmigration from the sinusoids was insufficient to incite 
significant hepatocyte apoptosis or additional neutrophil oxidative stress to cause 
hepatocellular damage.   Due to the lack of hepatocellular necrosis in the single dose 
study we decided to develop the model further by administering a second dose of LPS 
using the higher dose level.   
 Histopathology in the repeat dose study revealed marked midzonal necrosis, 
apoptosis and hepatic regeneration.  The mechanistic basis for such midzonal necrosis is 
recently shown to be due to alterations in hepatic microvasculature that is possibly 
iNOS dependent.   What is apparent in the two dose LPS study is the neutrophil 
“priming” effect by the first LPS dose with significant histopathologic necrotic lesions 
following administration of the second LPS dose. It is reasonable to surmise that the 
initial exposure to physiologically stressful levels of LPS cause neutrophil activation 
and initiate production of ROS and inflammatory mediators and CXC  chemokines 
which promote further hepatocellular oxidative stress (Gujral et al., 2003).  In the 
absence of adequate LPS clearance/recovery time, a second “hit” of LPS likely 
promotes a higher degree of oxidative stress, cytokines, chemokines  and adhesion 
molecules such as ICAM1, VCAM1 resulting in marked neutrophil infiltration and 
necrosis.  Others have also reported increased liver sensitivity and pathology to even 
innocuous levels of LPS after a “priming” event (Pirisi et al., 2000, Banerjee et al., 
2006).   
 In conclusion, we have developed a reliable LPS-mediated neutrophilic necro-
hepatitis model by administration of LPS in a repeat dose fashion which served as our 
test system as described in the next chapter.  Midzonal hepatic necrosis, absolute 
peripheral neutrophilia, hepatic neutrophil infiltration and upregulation of the CD11b 
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neutrophil adhesion molecule were identified as the most significant and consistent 
markers of LPS mediated effects in this model.  However, neither traditional serum 
biochemical parameters that detect liver injury nor neutrophil adhesion molecules 
reliably detected the observed liver injury and hepatic necrosis in this model.    
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CHAPTER III 
CALPAIN AND LIPOPOLYSACCHARIDE MEDIATED HEPATITIS 
MATERIALS AND METHODS 
Animals and treatment   
All animal procedures were approved by the Texas A&M University Laboratory 
Animal Care Committee (ULACC) and conformed to the standards set forth in the 
Guide for the Care and Use of Laboratory Animals (NRC 1996).  All rats were barrier 
raised rodents obtained from a commercial vendor (Harlan, Indianapolis, IN) and were 
housed in an AAALAC accredited facility.  Standard rodent chow (Teklad 8604, 
Madison WI) and reverse osmosis water were supplied ad libitum. 
Description of the endotoxin neutrophilic hepatitis model:  Two doses of LPS 
(10 mg/kg, i.v via the tail vein) were administered to male Sprague Dawley rats (250-
270 g body weight) 24 hrs apart based on pilot studies performed in our laboratory.   All 
sample collection times in this study occurred 6 hours after the second set of LPS 
injections.  Samples from saline treated control animals were taken concurrent with 
treated animals. Inhibitors were administered one hour prior to each dose of LPS (Fig. 
6).   
Calpain inhibitor pilot study:  Male Sprague Dawley rats (250-270 g body 
weight) were divided into three groups (N=5).  One group served as a saline vehicle 
control. A second group received LPS (E Coli serotype 0111: B4, Sigma Chemical Co., 
St Louis, MO) at a dose of 10 mg/kg iv in saline twice at 24 hour intervals. The third 
group was administered calpain 1 inhibitor (Sigma Chemical Co., St. Louis, MO.) at 10 
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mg/kg i.p. followed one hour later by LPS in saline at a dose of 10 mg/kg via tail vein 
injection with a second dose of calpain inhibitor and LPS treatment 24 hours later.  All 
rats were sacrificed via CO2 inhalation 6 hours after the second LPS injection.  
 
 
InhibitorInhibitor 
LPS  
6hr1hr1hr
LPS    
24 hours
24 hours Rats Sacrificed
 
Figure 6- Experimental protocol to develop LPS mediated hepatitis model and strategy for 
calpain, iNOS and coagulation inhibition experiments.    Male Sprague-Dawley rats (250-270 g) 
were injected two doses of LPS (10 mg/kg, i.v. via the tail vein 24 hrs apart to induce hepatitis.  
For inhibition experiments calpain 1 inhibitor (10 mg/kg, ip), iNOS inhibitor (aminoguanidine, 
45 mg/kg, ip) and coagulation inhibitor (heparin, 1000 IV/kg, S.C) were administered in 
separate experiments one hour prior to first LPS injection.   Appropriate controls were included 
for each treatment groups.  Rats were sacrificed 6 hours after the second injection of LPS.  
Details of the experimental protocol have been described in Materials and methods. 
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 Comparison of calpain inhibition with aminoguanidine (iNOS inhibitor) and 
heparin (coagulation inhibitor): Male Sprague Dawley rats (250-270 g body weight) 
were divided into five groups (N = 6).  One group served as a saline vehicle control 
with the four other groups administered LPS in saline twice, 24 hours apart, via tail vein 
injection at a dose of 10 mg/kg.  One hour prior to each dose of LPS, one group 
received calpain 1 inhibitor (Sigma, St Louis, MO) in DMSO at a dose of 10 mg/kg i.p.  
A second group received the relatively selective iNOS inhibitor aminoguanidine 
(Sigma, St Louis, MO) in saline at a dose of 45 mg/kg intraperitoneally one hour prior 
to each LPS dose.  A third group received heparin sodium (America Pharmaceutical 
Partners, Schaumburg, IL) at a dose of 1000 units/kg subcutaneously one hour prior to 
each LPS dose. The rats were sacrificed via CO2 inhalation 6 hours after the second 
injection of LPS. 
Sample collection and processing   
Whole blood was collected via the abdominal vena cava and immediately 
transferred to a lithium heparin, EDTA or sodium citrate tube (Monoject, Sherwood 
Medical, St Louis, MO).  The samples in lithium heparin tubes were used for evaluation 
of neutrophil activation via flow cytometry.  Samples in EDTA tubes were used for 
hematology evaluation and the samples in sodium citrate tubes were used to assess 
coagulation parameters.  Representative liver sections were collected from different 
lobes of the liver and placed in liquid nitrogen and stored at   -70° C for further analysis.  
The remaining liver along with sections of the lung and kidney were collected and 
placed in 10% neutral buffered formalin.  The liver was processed and slides stained 
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with hematoxylin and eosin (H&E) for histopathological evaluation or stained with 
choloracetate esterase for evaluation of hepatic neutrophil infiltration.  Kidney and lung 
sections were processed and stained with Mallory’s phosphotungstic acid hematoxylin 
(PTAH) for evaluation of fibrin.   
Flow cytometry studies 
To investigate treatment effects on neutrophil activation, heparinized whole 
blood samples from three rats per group were used to assess the neutrophil adhesion 
molecules, L-selectin (CD62-L) and Mac-1 (CD11b/18).  Blood was divided into 250 
uL aliquots in separate glass tubes and was kept on ice unless otherwise stated.  
Duplicate tubes of blood were designated to antibody stained or unstained groups.  Prior 
to staining with the appropriate conjugated antibody, 10µl of reagent grade mouse IgG 
(Sigma, St Louis, MO) mixed at a concentration of 1mg/ml was added to all but the 
unstained samples to reduce nonspecific binding of the conjugated antibodies.  In the 
next step, neutrophils in designated tubes were labeled with fluorescein-conjugated HIS 
48 (BD Biosciences, San Jose, CA), Mac 1 integrins were labeled with R-phycoerythrin 
conjugated CD11b and L-selectins were labeled using R-phycoerythrin CD62L 
(Serotec, Raleigh, NC).  Following incubation with antibodies (20 min), the samples 
were treated with RBC lysis buffer for 10 min.  The tubes were then centrifuged at 1000 
rpm for 10 min at 3° C and resuspended several times with the lysis buffer until 
erythrocytes were removed.  After lysing steps, the cells were washed with 250 µL of 
PBS and centrifuged at 1000 rpm for 10 minutes. Cells were re-suspended in 300 µL of 
PBS for analysis.   
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The cells were analyzed using a FACS Calibur (Becton Dickinson 
Immunocytometry Systems, San Jose, CA) flow cytometry, equipped with a 15mW air-
cooled argon laser. Green fluorescence from fluorescein was collected through a 
530/30-nm bandpass filter and orange fluorescence from R-phycoerythrin through a 
585/42-nm bandpass filter. List mode data was acquired on a minimum of 10,000 
events defined by light scatter gates to include the neutrophil population. Data analysis 
including spectral compensation was performed using FlowJo (Treestar Inc., Ashland, 
OR).  A neutrophil gate was established based on side scatter and positive HIS48 
staining, and the median fluorescence channel was determined for CD11b staining. 
Hematology evaluation (calpain inhibitor pilot study only) 
Complete blood counts for all animals in the calpain inhibitor pilot study were 
performed on a Cell-Dyn 3700 (Abbott Diagnostics, Abbott Park, IL) hematology 
analyzer.  Wright-Geimsa stained blood smears were also evaluated microscopically to 
determine hematologic abnormalities. 
Histopathology/hepatic neutrophil infiltration 
Cross sections of liver collected from the left lateral and median lobes were 
fixed in 10% neutral buffered formalin, processed by standard histological methods, and 
embedded in paraffin. 5 micron thick sections were stained with hematoxylin and eosin 
and evaluated for oncotic necrosis and apoptosis.   Two liver sections per rat were 
evaluated with the reviewer blinded to the treatment groups.  Lesions were scored using 
a semiquantitative scale as follows: 
Lesion score (mean of two sections): 
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0- no evidence of lesions  
1- periportal infiltrate only 
2- periportal infiltrate with ≤ 2 foci of necrosis 
3- periportal infiltrate with 3-5 foci of necrosis 
4- periportal infiltrate with ≥ 6 foci of necrosis 
Distribution score 
P- periportal predominate 
M- midzonal predominate 
C- centrilobular predominate 
The H&E staining was also employed to identify the neutrophils, based on the 
segmented morphology of the nucleus.  To quantitate the degree of neutrophilic 
inflammation, unstained paraffin embedded slides were deparaffinized then stained with 
a chloroactetate esterase kit (Sigma, St Louis, MO) according to the manufacturer’s 
recommendations.  The number of neutrophils in 10 randomly chosen high power fields 
(20X) were recorded and the results expressed as the mean number per 20X field as 
described previously (Banerjee et al., 2006). To evaluate the effect of circulating 
microthrombi in this model, cross sections of the left lung lobe and longitudinal cross 
sections of the left kidney were fixed in neutral buffered formalin, processed by 
standard histological methods and embedded in paraffin.  5 micron sections were 
stained with phosphotungstic acid hematoxylin solution and evaluated for the presence 
of fibrin.  The number of fibrin foci in 10 randomly chosen low power fields (10X) 
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were recorded and the results expressed as the mean number per 10X field for kidney 
and lung sections.      
 
 
Western blot analysis for iNOS and α-fodrin   
α-Fodrin is a substrate for calpain and was used to confirm calpain inhibiton.  
Liver lysates were prepared by grinding 300 mg frozen liver suspended in liquid 
nitrogen with a mortar and pestle in a lysis buffer containing 1% Triton X-100, 150 mM 
NaCl, 10 mM Tris (pH 7.4), 1 mM EDTA, 1 mM EGTA, 2 mM Na vanadate, 0.2 ml 
PMSF (200 mM PMSF in isopropanol), 1 mM Hepes (pH 7.6), 1 µg/ml leupeptin, and 1 
µg/ml aprotinin. Sample protein concentrations were determined using the method of 
Bradford (Bradford, 1976).  Polyacrylamide gel (8%) electrophoresis was employed for 
α-fodrin analysis and 10% gel was employed to assess iNOS expression.  After 
transferring the proteins onto nitrocellulose membranes, the membranes were blocked 
for 3 hours with 6% milk made with 1X TBS/Tween 20. After the blocking step, the 
membranes were incubated with primary rabbit polyclonal antibody for α-fodrin at 
1:2500 dilution (Abcam, Cambridge, MA) and rabbit polyclonal antibody for iNOS at 
1:2000 dilution (Cayman chemical company, Ann Arbor, MI).   Subsequently, the 
nitrocellulose membrane was incubated with secondary goat anti rabbit antibody 
(Kirkgaard and Perry Labs, Gaithersburg, MD) in 2% milk made with 1X TBS/Tween 
20 at a 1:4000 dilution.  The blots were visualized using enhanced chemiluminescence 
kit (Pierce, Rockford, IL). 
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Western blot analysis for cytochrome P450 (CYP) 2E1 
Preparation of microsomes:  Frozen liver tissue was homogenized (1:5 w/v) 
using an Ultra-Turrax 25 homogenizer (IKA, Wilmington, NC) in ice-cold Tris-acetate 
buffer (pH 7.4) containing 1.15% KCl.  The homogenate was centrifuged at 10,000g for 
30 min at 4°C.  The supernatant was decanted and centrifuged at 100,000g for 60 min at 
4°C.  Microsomal pellets were resuspended, manually homogenized and again 
centrifuged at 100,000g for 60 min at 4°C.  Microsomal pellets were again recovered, 
suspended in assay buffer (pH 7.4), manually homogenized then quick frozen and 
stored at -70°C for later use.  Sample protein concentrations were determined using the 
method of Bradford (Bradford, 1976).      
Western blot analysis for CYP2E1: Microsomal protein from each rat was 
separated by SDS polyacrylamide gel (10%) electrophoresis and transferred to 
nitrocellulose membrane. After the blocking step, the membrane was incubated with a 
rabbit anti-human polyclonal anti-CYP2E1 primary antibody, 1:1000 dilution 
(generously gifted by Dr. Jerry Lasker,  Hackensack University Medical Center, New 
Jersey ) for 2 hours and further probed with HRP-linked goat anti-rabbit secondary 
antibody (Kirkgaard and Perry Labs, Gaithersburg, MD; 1;10,000 dilution) for 1 hr. 
Primary Rabbit polyclonal antibody for cytochrome 4A was supplied by Abcam 
(Cambridge, MA).  The blots were visualized using enhanced chemiluminescence 
(Pierce, Rockford, IL). 
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Coagulation parameters   
To determine treatment effects and confirm efficacy of heparin administration, 
the values for prothrombin time (PT) and activated partial thromboplastin time (APTT) 
were determined from citrated blood samples collected from 3 rats per selected group 
(control, LPS only and LPS plus heparin) using the Beckman Coulter ACL 9000 
coagulation analyzer (Fullerton, CA). 
 
Statistics   
To identify significant differences among groups, analysis of variance 
(ANOVA) with a post hoc Tukey’s HSD was performed using a computer software 
program (SPSS version 12.0, Claritas Inc.).  Results were considered significant at the 
0.05 confidence level. 
RESULTS 
Clinical signs 
No mortalities were recorded.  Rats administered LPS alone appeared more 
lethargic than rats in the other groups and developed diarrhea within 1-2 hours after 
LPS administration.  Rats given LPS plus calpain1 inhibitor appeared more lethargic 
than untreated controls but were brighter subjectively than LPS only rats.  Rats 
administered LPS plus calpain 1 inhibitor developed diarrhea but the time to onset was 
slower (4-6 hours) as compared to LPS only rats.  Rats given LPS plus aminoguanidine 
or LPS plus heparin appeared similar to rats administered LPS plus calpain 1 inhibitor.  
Due to the short duration of these studies (a total of 30 hours from initial LPS injection), 
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post treatment body weights, food consumption and water consumption were not 
measured. 
Flow cytometry   
The neutrophil adhesion molecule CD11b was significantly upregulated in the 
LPS, and LPS plus calpain 1 inhibitor as compared to untreated controls confirming 
neutrophil activation in both the calpain 1 inhibitor and the comparison study. CD 11b 
was also significantly upregulated in the LPS plus aminoguanidine and LPS plus 
heparin groups as compared to untreated controls in the comparison study (Fig. 7).  
However, when comparison of CD11b levels was made between aminoguanidine and 
heparin with calpain inhibitor a mild decrease in neutrophil activation was noted. 
Hematology (calpain inhibitor pilot study only) 
Absolute neutrophil counts and neutrophil to lymphocyte ratios were elevated in 
LPS and LPS plus calpain 1 inhibitor groups as compared to untreated controls.  There 
was no significant difference in absolute neutrophil numbers or neutrophil to 
lymphocyte ratio between LPS and LPS plus calpain 1 inhibitor groups (Table 3). 
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Figure 7- Flow cytometric analysis of CD11b expression.  Neutrophils from different treatment 
groups were labeled with fluorescein-conjugated HIS48 and CD11b antibodies as described in 
the Materials and methods section.  The scale represents median fluorescence. *Values 
significantly different from the controls.  Data are expressed as mean±SE, p≥0.05. 
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Table 3.  Absolute neutrophil count, neutrophil to lymphocyte ratio (N:L) , liver 
pathology score, and hepatic neutrophil scoring in the calpain inhibitor (CI) study 
evaluated in rat endotoxin (LPS) hepatitis model. 
 
Parameter Control LPS LPS + CI 
Neutrophil (absolute number/µl) 1796 ± 882 4156 ± 878a 4710 ± 1377a  
Neutrophil to lymphocyte ratio .2 ± 0.2 1.8 ± 0.6a 1.9 ± .7a
Liver Pathology Score/ Lesion 
Distribution 
0 ± 0/na 3.6 ± .5c/M 1.2 ± .4a,b/P 
Liver Neutrophil Count 
(per 20X field) 
1.2 ± .4 16.4 ± 2.3a 7.0 ± 1.0a,b
 
 
 
 
 
 
 
 
 
 
Absolute neutrophil count was performed on an automated Cell-Dyne counter and evaluated 
manually on blood smears.  Hepatic neutrophils were counted as the number of neutrophils per 
five high power fields as described in the materials and methods section. Values are mean ± SD. 
n = 5 
na = not applicable 
P = periportal 
M = midzonal 
a = significant as compared to control group 
b = significant as compared to LPS only group 
c = significant as compared to control and inhibitor group 
 
 
Histopathology  
Neutrophilic midzonal hepatocyte oncotic necrosis with apoptosis and periportal 
mononuclear inflammatory cell infiltrates were a major feature in the LPS only group as 
demonstrated by semiquantitative scoring (Tables 3 and 4) compared to the controls 
(Figs. 8 A-C).  Significant decreases in necrosis and neutrophilic inflammation was 
identified in all of the inhibitor groups as demonstrated by semiquantitative scoring 
(Tables 3 and 4), although rare necrotic foci was identified in the iNOS inhibitor group 
(Figs. 8 D-F).  There was reduction in fibrin deposition in the PTAH stained lung and 
kidney of only the heparin plus LPS group as compared to the LPS only group (Table 
4). No significant difference in fibrin deposition was found in the lung or kidney among 
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the calpain 1 inhibitor or aminoguanidine groups as compared to the LPS only group 
(Table 4). 
Neutrophil scoring 
Calpain 1 inhibitor study:  There were significant differences in liver neutrophil 
counts among the three groups (Table 3).  Control rats had significantly lower 
neutrophil counts as compared to all the other groups (1.2 per 20X field). LPS only rats 
had the highest neutrophil counts with a mean of 16.4 neutrophils per 20X field.  
However, administration of calpain 1 inhibitor significantly decreased the hepatic 
neutrophils counts (7.0 per 20X field).   
Comparison study: Control rats had significantly lower neutrophil counts as 
compared to all other groups in the comparison study (Table 4).  LPS only rats had the 
highest hepatic neutrophil counts with a mean of 16.5 neutrophils per 20X field which 
was significantly higher than any other group.  The LPS plus calpain 1 inhibitor group 
had a mean hepatic neutrophil count of 3.6 neutrophils per 20X field which was 
significantly reduced as compared to LPS alone group.  Hepatic neutrophil counts for 
the heparin and aminoguanidine groups were significantly lower than the LPS only 
group but not different from the LPS plus calpain 1 inhibitor group. 
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Figure 8- Representative photomicrographs of H&E stained liver sections. A: control 10X 
magnification; B: repeat dose LPS 10X magnification; C: repeat dose LPS 40X magnification; 
D: LPS plus calpain inhbitor 20X magnification; E: LPS plus aminoguanidine 20X 
magnification and F: LPS plus heparin 20X magnification. Rats were sacrificed six hours 
following second dose LPS injection in all groups.   Circled areas indicate midzonal necrosis 
and arrows indicate periporal infiltrates. 
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Table 4- Summary  results of semiquantitative liver pathology score, lung and kidney 
thrombi count, hepatic neutrophil count and coagulation times (PT and PTT) in the 
calpain inhibitor (CI), iNOS inhibitor (aminoguanidine, AG) and coagulation inhibitor  
(heparin, Hep) groups in the endotoxin (LPS) mediated hepatitis model. 
 
 
 
Parameter Control LPS LPS + CI LPS + 
AG  
LPS + 
Hep 
Liver Pathology Score/ 
Lesion  Distribution 
0 ± 0/na 3.7 ± .5c/M 0.7 ± .5/P 1.3 ± .4a/P 0.8 ±.4a/P 
Liver Neutrophil Count 
(per 20X field) 
0.9 ± 1.0 16.5 ± 2.1a 3.6 ± 1.5a,b 6.5 ± 0.5a,b 4.8 ± 0.4a,b
Lung Thrombi Count 
(per 10X field) 
0.1 ± .2 2.8 ± .6a 3.0 ± .5a 2.9 ± .7a .9 ± .4 
Kidney Thrombi Count 
(per 10X field) 
.1 ± .2 6.1 ± 1.1a 5.4 ± 1.2a 6.5 ± 1.2a 0.3 ± 0.1 
PT (sec) 15.4 ± 0.8 14.7 ± .6 N/A N/A 20.1 ± 1.2a,b
APTT (sec) 11.0 ± 3.7 18.8 ± 3.3a N/A N/A >248a,b
Lung and kidney thrombi count and hepatic neutrophil count were evaluated in ten high power 
fields as described in the materials and methods section.  Coagulation analysis was evaluated by 
measuring prothrombin time (PT in secs) and activated partial thromboplastin time (APTT in 
secs) of the extrinsic and intrinsic coagulation pathways respectively.  Values are mean ± SD, n 
= 6. 
na = not applicable 
P = periportal 
M = midzonal 
a = significant as compared to control group 
b = significant as compared to LPS only group 
c = significant as compared to control and inhibitor groups 
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Coagulation parameters   
The mean PT and APTT values were employed to detect inhibition of major 
pathways of coagulation.  PT and APTT values for the LPS plus heparin group were 
elevated as compared to the control and LPS only groups confirming inhibition of 
coagulation by heparin (Table 4). APTT values were elevated by LPS alone compared 
to the controls with further prolongation of APTT values by heparin.   
Western blotting 
 α-fodrin: To evaluate the degradative effect of released calpain on its substrate 
α-fodrin, a Western blotting technique was used. Calpain is known to degrade the 240-
kDa α-subunit of fodrin at several sites to produce breakdown products including a 150 
kDa, 120 kDa and 35 kDa product (Abcam α-fodrin antibody data sheet).  In normal 
control rat livers almost all α-fodrin was in intact form. The native form of α-fodrin was 
significantly higher in the LPS plus calpain 1 inhibitor groups as compared to the LPS 
only group confirming calpain inhibition (Fig.9).  Comparing relative densitometry 
results, there was no significant difference in α-fodrin degradation between LPS only 
and aminoguanidine and heparin groups (p- 0.96) indicating that these two inhibitors do 
not inhibit calpain in our model. 
Western blotting for iNOS:  iNOS expression was significantly lower in the 
calpain 1 inhibitor group as compared to the LPS only group and the levels were 
comparable to the untreated control group (Fig. 10).  iNOS expression in the 
aminoguanidine and heparin groups was also significantly lower than the LPS only 
group and was comparable to the calpain 1 inhibitor group (Fig. 10).  To complement 
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measurement of iNOS expression via immunoblotting, iNOS activity can also be 
measured by in vitro assay of L-arginine conversion to L-citrulline.  As reported by 
many investigators including Jinnou-Oue and colleagues (2003), immunoblotting 
results are generally strongly correlated to iNOS activity.  Because of this correlation 
we chose to employ western blotting techniques as indicators of iNOS effects in this 
model. 
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Figure 9- Representative western blotting showing α- fodrin degradation in LPS mediated 
hepatitis and the calpain inhibitor group. GAPDH was employed as internal loading control  to 
ensure equal loading of proteins.  * Values significantly different from the controls and inhibitor 
treatment groups.  # values significantly different from controls at p≤ 0.05. 
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Figure 10- Representative western blotting showing iNOS expression in LPS mediated hepatitis 
and various inhibitor groups.  GAPDH was employed as internal loading control  to ensure 
equal loading of proteins.  * Values significantly different from the controls and inhibitor 
treatment groups.  # values significantly different from controls at p≤ 0.05. 
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Western blotting for CYP2E1: CYP2E1 expression was down-regulated in the 
LPS only group as compared to calpain 1 inhibitor and untreated controls.   There was 
no significant difference between CYP2E1 expression among the aminoguanidine and 
heparin groups as compared to calpain 1 inhibitor and untreated controls (Fig. 11). To 
complement measurement of CYP expression via immunoblotting, CYP enzyme 
activity can also be measured by chlorazone 6-hydroxylase and p-nitrophenol 
hydroxylase assay.  Results obtained in our lab and as reported by others indicate CYP 
activity is strongly correlated to CYP expression when employing an appropriate 
primary antibody that minimizes cross reaction (Amato et al., 1998; Turner et al., 1988).  
Because of this strong correlation, we chose to use western blotting techniques as an 
indicator of cytochrome effects in this model. 
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Figure 11- Representative western blotting showing CYP2E1 proteins in LPS mediated hepatitis 
and various inhibitor groups.  * Values significantly different from the controls and inhibitor 
treatment groups. 
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CHAPTER IV 
DISCUSSION AND CONCLUSION 
DISCUSSION 
The above experiments investigated the protective role of calpain in a LPS 
mediated neutrophilic hepatitis model in the rat.  The interesting observation noted in 
this model was the exclusive midzonal distribution of necrosis.  Although, midzonal 
lesions have been described by others during states of endotoxemia, these lesions were 
generally accompanied by periportal necrosis (Katsushige et al., 2005; Pirisi et al., 
2000). However, the necrosis in the present study originated primarily in the midzonal 
region following increased neutrophil infiltration as noted during the model 
development phase performed in our lab (Rose et al., manuscript submitted). Primary 
midzonal hepatic lesions are uncommon but have been associated with viral yellow 
fever and shock associated hypotension (de la Monte et al., 1984).  Yee and coworkers 
have also described midzonal necrosis following large doses of LPS in rats (Yee et al., 
2003). It is reported that excessive production of nitric oxide (NO) as a consequence of 
macrophage release of iNOS contributes to the hypotension which is a feature of 
endotoxemia (Imai et al., 1994; Landry and Oliver, 2001).  NO is known to play a dual 
role in the liver during inflammatory states with low levels of NO, produced consequent 
to activation of constitutive eNOS, shown to be protective and higher levels of NO, as a 
result of iNOS release, demonstrated to be cytotoxic (Rocky and Shah, 2004). Based on 
these reports, the midzonal distribution of hepatic lesions seen in this study is proposed 
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to be the result of a combination of nitric oxide mediated hypotension by iNOS and 
subsequent oxidative stress secondary to circulatory impairment, and parenchymal 
migration and proteolytic enzyme release by neutrophils resulting in hepatocyte injury 
(Jaeschke and Smith, 1997, Lawson et al., 2000).   
The occurrence of midzonal necrosis combined with the fact that calpain 
inhibition decreased liver injury and neutrophil infiltration led us to investigate the 
relationship between calpain inhibition and iNOS.  One explanation for decreased 
hepatic neutrophil infiltration in the calpain 1 inhibitor group may simply be the result 
of decreased neutrophil numbers or decreased transmigration consequent to decreased 
neutrophil activation in the vasculature.  However, hematology and flow cytometry 
results revealed that neutrophilia and activation of neutrophils as measured by CD11b 
was not different between the LPS and LPS plus calpain 1 inhibitor groups.  Based on 
these results, it can be interpreted that the afforded protection by calpain inhibition is 
not solely due to decrease in peripheral neutrophil count or decreased neutrophil 
activation.  Although the neutrophil activation was decreased in the aminoguanidine and 
heparin group compared to the calpain 1 inhibitor group, there was enough 
neutrophil/leukocyte activation to account for hepatic neutrophil infiltration as 
evidenced by hepatic neutrophil counts and periportal infiltrates on histology. In light of 
the presence of adequate neutrophil activation and periportal neutrophil infiltrate in all 
treated groups, mechanisms other than neutrophil and vascular endothelial cell 
activation seem to be playing a role in the observed protection.   
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Noteworthy in our studies is the reduced expression of hepatic iNOS in the 
calpain 1 inhibitor group which coincided with reduced hepatic pathology. Inhibition of 
calpain is reported to block production of iNOS through an NF-κB dependent 
mechanism (Constantin et al., 2004; Kabori, 2006; Lancaster et al., 2001).   Asakura et 
al., (2005) also reported attenuation of liver and kidney pathology after administration 
of the iNOS inhibitor L-NIL in an LPS mediated rat model of DIC. Similarly Guler et 
al., (2004) have demonstrated protection from liver damage, as measured by 
histopathology, in iNOS deficient mice infected with mycobacteria after challenge with 
LPS.  
Similar to inhibition of iNOS by calpain inhibition, iNOS inhibition by 
aminoguanidine also resulted in significantly reduced neutrophils and liver pathology.  
These results are consistent with reports of Suliburk et al., (2005) who noted 
improvement in LPS mediated liver injury in rats, as measured by ALT and AST levels, 
after administration of aminoguanidine 1 hour prior to administration of LPS.   
Although we do not have cause and effect evidence (for example using iNOS knock out 
mice), the association of decreased iNOS with decreased neutrophil infiltration and 
necrosis suggests that iNOS inhibition is the possible reason for the observed protection 
of calpain inhibition noted in our model.  
Interestingly, heparin administration prior to LPS also reduced microscopic liver 
pathology and iNOS expression comparable to calpain 1 inhibition and aminoguanidine. 
Reduced microthrombi deposition was demonstrated in the lung and kidney of heparin 
administered rats in this study.  Moulin et al., (1996) reported that heparin 
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administration prior to LPS attenuates hepatocellular injury in rats as measured by ALT 
and histopathology in a thrombin dependent manner.  Also, in a model of liver 
transplantation, Vajdova et al., (2000) reported co-administration of heparin minimized 
endotoxin mediated preservation-reperfusion injury by prolonging coagulation and 
limiting microthrombi deposition. Microthrombi inhibition and preservation of 
microcirculation by heparin is reported to result in reduced hepatocyte oxidative stress 
which subsequently decreases iNOS expression in LPS mediated injury (Guler et al., 
2004; Suliburk et al., 2005).  Based on our findings and reports in the literature, it 
appears that the protective effect of heparin noted in the present study may partly be the 
result of decreased microthrombi deposition resulting in improved microperfusion.  We 
suggest that the reduction in hepatocyte damage resulted in reduced hepatocyte release 
of iNOS. 
Although the precise mechanism behind decreased iNOS and protection noted in 
the current study is not investigated, the following mechanism may have some 
underlying mechanistic influence. Attenuating NO dependent hypotension via iNOS 
inhibition in the present study is likely resulting in preserved liver microperfusion and 
reduced oxidative stress secondary to reduced tissue oxygenation (Fig. 12). Indeed, 
using intravital microscopy, Horie and co-workers (2000) reported reduced sinusoidal 
blood flow and increased endothelial-leukocyte adhesion predominately in the midzonal 
region after LPS administration in rats.  
Since CYP2E1 is known to be altered with endotoxin injection, we measured 
CYP2E1 protein to investigate if the observed protection mediated by calpain 1 
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inhibition is because of CYP2E1 inhibition.  Based on our results, it appears that it is 
less likely involved.  Finally emerging evidence suggests NO plays a role in 
epoxygenase dependent vascular responses via inhibition of CYP P450 enzymes 
(Udosen et al., 2003).  Inhibition of   NO production subsequent to LPS exposure might 
preserve epoxygenase dependent vasodilation that plays a role in maintaining 
microcirculation (Fleming, 2004).  We employed CYP2E1 as a model for LPS mediated 
CYP downregulation as this cytochrome’s response to LPS has been well documented 
(Morgan, 2001. Renton et al., 2000).  Administration of calpain 1 inhibitor preserved 
CYP2E1 expression which may suggest a role of iNOS inhibition and cytochrome 
expression in this model.  There is debate in the literature concerning NO 
downregulation of cytochromes and further mechanistic work is needed   (Sewer et al., 
1997; Sewer and Morgan, 1998; Vappugalla and Mehvar, 2004).  
CONCLUSION 
In summary, inhibition of calpain attenuated LPS induced midzonal hepatic 
necrosis in our two dose model of endotoxemia.  Lowered hepatic neutrophil migration 
along with attenuated midzonal necrosis consequent to calpain inhibition accompanied 
reduced iNOS expression as compared to LPS only administered rats.  Based on these 
findings and comparisons of the effect of calpain inhibition with those of 
aminoguanidine and heparin, which also decreased hepatic iNOS and neutrophil 
infiltration, we suggest that calpain inhibition reduces liver pathology via maintenance 
of hepatic microcirculation most likely in an iNOS dependent fashion.  
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Figure 12- The hypothesized role of iNOS in calpain inhibition mediated protection in a 
repeated dose endotoxin model of hepatitis.  Figure 7a demonstrates upregulated calpain 
mediated iNOS expression post LPS exposure.  Due to reduced circulation, activated 
neutrophils and microthrombi adhere to the sinusoidal endothelial wall promoting neutrophil 
transmigration and release of proteolytic enzymes.  Figure 7b demonstrates calpain inhibition 
with resulting downregulation of iNOS.  Improved microcirculation afforded by iNOS 
inhibition hinders activated neutrophil and microthrombi adhesion to the sinusoidal endothelium 
reducing neutrophil transmigration, proteolytic enzyme release and consequently decreased 
liver injury.  
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